PEPT
REX Peptide ETF
Price Chart
Latest Quote
$26.11
+0.23 (+0.88%)
Current Price
| Previous Close | $25.88 |
| Open | $26.07 |
| Day High | $26.11 |
| Day Low | $26.00 |
| Volume | 2,734 |
Fund Information
| Expense Ratio | 0.65% |
| Category | Health |
| Fund Family | Rex |
| Net Asset Value | $25.85 |
| Premium/Discount | 1.02% |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
Performance History
| Week | +0.15% |
| YTD | +4.19% |
| 10 Years | +4.19% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $26.11 | 2,700 |
| 2026-10-26 | $25.91 | 7,500 |
| 2026-10-23 | $25.82 | 7,400 |
| 2026-10-22 | $26.20 | 18,400 |
| 2026-10-21 | $26.03 | 13,100 |
| 2026-10-20 | $26.07 | 9,100 |
| 2026-10-19 | $25.36 | 4,400 |
| 2026-10-16 | $25.23 | 8,000 |
| 2026-10-15 | $25.56 | 14,400 |
| 2026-10-14 | $25.06 | 4,300 |
About REX Peptide ETF
It tracks the investment results, before fees and expenses, of the VettaFi Peptide Index? (the “Index”), which is designed to track the performance of equity securities of companies that are strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products—including therapeutics, supplements, cosmetics, and medical devices—along with the enabling technologies essential for peptides. The fund is non-diversified.
📰 Latest News
No news articles available at the moment. Check back later for updates on PEPT.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.